Literature DB >> 29869170

Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease.

Aiguo Han1, Yassin Labyed2, Ethan Z Sy3, Andrew S Boehringer3, Michael P Andre4,5, John W Erdman6, Rohit Loomba7, Claude B Sirlin3, William D O'Brien8.   

Abstract

OBJECTIVES: To assess inter-sonographer reproducibility of ultrasound attenuation coefficient (AC), backscatter coefficient (BSC) and shear wave speed (SWS) in adults with known/suspected non-alcoholic fatty liver disease (NAFLD).
METHODS: The institutional review board approved this HIPAA-compliant prospective study; informed consent was obtained. Participants with known/suspected NAFLD were recruited and underwent same-day liver examinations with a clinical scanner. Each participant was scanned by two of the six trained sonographers. Each sonographer performed multiple data acquisitions in the right liver lobe using a lateral intercostal approach. A data acquisition was a single operator button press that recorded a B-mode image, radio-frequency data, and the SWS value. AC and BSC were calculated from the radio-frequency data using the reference phantom method. SWS was calculated automatically using product software. Intraclass correlation coefficient (ICC) and within-subject coefficient of variation (wCV) were calculated for applicable metrics.
RESULTS: Sixty-one participants were recruited. Inter-sonographer ICC was 0.86 (95% confidence interval: 0.77-0.92) for AC and 0.87 (0.78-0.92) for log-transformed BSC (logBSC = 10log10BSC) using one acquisition per sonographer. ICC was 0.88 (0.80-0.93) for both AC and logBSC averaging 5 acquisitions. ICC for SWS was 0.57 (0.29-0.74) using one acquisition per sonographer, and 0.84 (0.66-0.93) using 10 acquisitions. The wCV was ~7% for AC, and 19-43% for SWS, depending on number of acquisitions.
CONCLUSIONS: Hepatic AC, BSC and SWS measures on a clinical scanner have good inter-sonographer reproducibility in adults with known or suspected NAFLD. Multiple acquisitions are required for SWS but not AC or BSC to achieve good inter-sonographer reproducibility. KEY POINTS: • AC, BSC and SWS measurements are reproducible in adults with NAFLD. • Inter-sonographer reproducibility of SWS measurement improves with more acquisitions being averaged. • Multiple acquisitions are required for SWS but not AC or BSC.

Entities:  

Keywords:  Elastography; Liver fibrosis; Non-alcoholic fatty liver disease; Reproducibility of results; Ultrasonography

Mesh:

Year:  2018        PMID: 29869170      PMCID: PMC7235946          DOI: 10.1007/s00330-018-5541-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

Authors:  Jeremy S Paige; Gregory S Bernstein; Elhamy Heba; Eduardo A C Costa; Marilia Fereirra; Tanya Wolfson; Anthony C Gamst; Mark A Valasek; Grace Y Lin; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Rohit Loomba; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

2.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Authors:  Magali Sasso; Michel Beaugrand; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Raoul Poupon; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2010-09-27       Impact factor: 2.998

3.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.

Authors:  Mirella Fraquelli; Cristina Rigamonti; Giovanni Casazza; Dario Conte; Maria Francesca Donato; Guido Ronchi; Massimo Colombo
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

4.  Repeatability and Reproducibility of a Clinically Based QUS Phantom Study and Methodologies.

Authors:  Aiguo Han; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2016-07-09       Impact factor: 2.725

5.  Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Mark L Palmeri; Michael H Wang; Ned C Rouze; Manal F Abdelmalek; Cynthia D Guy; Barry Moser; Anna Mae Diehl; Kathryn R Nightingale
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

6.  Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.

Authors:  Aiguo Han; Michael P Andre; Lisa Deiranieh; Elise Housman; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  J Ultrasound Med       Date:  2018-01-23       Impact factor: 2.153

7.  WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver.

Authors:  Giovanna Ferraioli; Carlo Filice; Laurent Castera; Byung Ihn Choi; Ioan Sporea; Stephanie R Wilson; David Cosgrove; Christoph F Dietrich; Dominique Amy; Jeffrey C Bamber; Richard Barr; Yi-Hong Chou; Hong Ding; Andre Farrokh; Mireen Friedrich-Rust; Timothy J Hall; Kazutaka Nakashima; Kathryn R Nightingale; Mark L Palmeri; Fritz Schafer; Tsuyoshi Shiina; Shinichi Suzuki; Masatoshi Kudo
Journal:  Ultrasound Med Biol       Date:  2015-03-20       Impact factor: 2.998

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

9.  Beyond Cervical Length: A Pilot Study of Ultrasonic Attenuation for Early Detection of Preterm Birth Risk.

Authors:  Barbara L McFarlin; Viksit Kumar; Timothy A Bigelow; Douglas G Simpson; Rosemary C White-Traut; Jacques S Abramowicz; William D O'Brien
Journal:  Ultrasound Med Biol       Date:  2015-08-08       Impact factor: 2.998

10.  Acoustic radiation force impulse and supersonic shear imaging versus transient elastography for liver fibrosis assessment.

Authors:  Ioan Sporea; Simona Bota; Ana Jurchis; Roxana Sirli; Oana Grădinaru-Tascău; Alina Popescu; Iulia Ratiu; Milana Szilaski
Journal:  Ultrasound Med Biol       Date:  2013-08-09       Impact factor: 2.998

View more
  13 in total

1.  Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.

Authors:  Aiguo Han; Yingzhen N Zhang; Andrew S Boehringer; Vivian Montes; Michael P Andre; John W Erdman; Rohit Loomba; Mark A Valasek; Claude B Sirlin; William D O'Brien
Journal:  Radiology       Date:  2020-02-04       Impact factor: 11.105

2.  Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method.

Authors:  Joe L Rowles; Aiguo Han; Rita J Miller; Jamie R Kelly; Catherine C Applegate; Matthew A Wallig; William D O'Brien; John W Erdman
Journal:  Nutr Res       Date:  2018-12-14       Impact factor: 3.315

3.  Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.

Authors:  Aiguo Han; Yingzhen N Zhang; Andrew S Boehringer; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  Eur Radiol       Date:  2019-02-19       Impact factor: 5.315

4.  A Phantom-Based Assessment of Repeatability and Reproducibility of Transvaginal Quantitative Ultrasound.

Authors:  Shi Chen; Barbara L McFarlin; Barbara T Meagher; Tara A Peters; Douglas G Simpson; William D O'Brien; Aiguo Han
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2019-06-14       Impact factor: 2.725

5.  Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.

Authors:  Jinho Jung; Aiguo Han; Egbert Madamba; Ricki Bettencourt; Rohan R Loomba; Andrew S Boehringer; Michael P Andre; John W Erdman; William D O'Brien; Kathryn J Fowler; Claude B Sirlin; Rohit Loomba
Journal:  Radiology       Date:  2022-03-29       Impact factor: 29.146

Review 6.  Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.

Authors:  Nobuharu Tamaki; Veeral Ajmera; Rohit Loomba
Journal:  Nat Rev Endocrinol       Date:  2021-11-23       Impact factor: 47.564

7.  Hepatic steatosis assessment using ultrasound homodyned-K parametric imaging: the effects of estimators.

Authors:  Zhuhuang Zhou; Qiyu Zhang; Weiwei Wu; Ying-Hsiu Lin; Dar-In Tai; Jeng-Hwei Tseng; Yi-Ru Lin; Shuicai Wu; Po-Hsiang Tsui
Journal:  Quant Imaging Med Surg       Date:  2019-12

Review 8.  Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Arinc Ozturk; Chetan K Potu; Ashley L Louie; Vivian Montes; Walter C Henderson; Kang Wang; Michael P Andre; Anthony E Samir; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2019-03-12       Impact factor: 4.813

9.  Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.

Authors:  Aiguo Han; Michal Byra; Elhamy Heba; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  Radiology       Date:  2020-02-25       Impact factor: 29.146

Review 10.  Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.

Authors:  Yasushi Honda; Masato Yoneda; Kento Imajo; Atsushi Nakajima
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.